Received Nov 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
took a Flu Shot patient was sick for 2 to 3 weeks; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. Co-suspect products included Flu unspecified (Flu vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine and Flu vaccine. On an unknown date, an unknown time after receiving RSV vaccine and Flu vaccine, the patient experienced sickness (Verbatim: took a Flu Shot patient was sick for 2 to 3 weeks). The outcome of the sickness was resolved. It was unknown if the reporter considered the sickness to be related to RSV vaccine and Flu vaccine. It was unknown if the company considered the sickness to be related to RSV vaccine and Flu vaccine. Additional Information: GSK Receipt Date: 25-OCT-2025 This case was reported by a patient via interactive digital media. The patient reported discontinuing government-administered vaccines approximately 40 years ago. The patient stated that prior to discontinuation, each influenza vaccination resulted in illness lasting 2 to 3 weeks. The batch number was not provided, and we are unable to contact the reporter.